Home/Filings/4/0001437749-22-028940
4//SEC Filing

AUERBACH ALAN H 4

Accession 0001437749-22-028940

CIK 0001401667other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 7:58 PM ET

Size

4.7 KB

Accession

0001437749-22-028940

Insider Transaction Report

Form 4
Period: 2022-12-12
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Common Stock

    2022-12-12$4.40/sh+568,181$2,499,9966,879,879 total
Footnotes (1)
  • [F1]On December 9, 2022, the Issuer entered into a Securities Purchase Agreement with the Reporting Person, pursuant to which these shares were purchased by the Reporting Person at the closing on December 12, 2022 for $4.40 per share.

Issuer

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667

Entity typeother

Related Parties

1
  • filerCIK 0001358285

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 7:58 PM ET
Size
4.7 KB